Basit öğe kaydını göster

dc.contributor.authorBengu, Demirag
dc.contributor.authorCanan, Vergin
dc.contributor.authorBurcak, Tatli Gunes
dc.contributor.authorEsin, Albudak
dc.contributor.authorSelim, Badur
dc.contributor.authorYontem, Yaman
dc.contributor.authorIlker, Devrim
dc.contributor.authorYesim, Oymak
dc.contributor.authorAysen, Turedi
dc.contributor.authorGulcihan, Ozek
dc.contributor.authorOzgur, Carti
dc.contributor.authorMeral, Akcay Ciblak
dc.date.accessioned2021-03-04T14:03:52Z
dc.date.available2021-03-04T14:03:52Z
dc.date.issued2013
dc.identifier.citationYontem Y., Ilker D., Yesim O., Aysen T., Gulcihan O., Ozgur C., Meral A. C. , Burcak T. G. , Bengu D., Esin A., et al., "Analysis of Fatal Cases of Pandemic Influenza A (H1N1) Virus Infections in Pediatric Patients with Leukemia", PEDIATRIC HEMATOLOGY AND ONCOLOGY, cilt.30, sa.5, ss.437-444, 2013
dc.identifier.issn0888-0018
dc.identifier.othervv_1032021
dc.identifier.otherav_7f9a3583-2084-42e0-bc81-898d8419b222
dc.identifier.urihttp://hdl.handle.net/20.500.12627/87084
dc.identifier.urihttps://doi.org/10.3109/08880018.2013.796025
dc.description.abstractBackground: Pandemic influenza A/H1N1/2009 virus usually causes mild illness in healthy children. Chronic medical conditions are recognized as increasing the risk for complications of influenza virus infection. Although most studies including children with acute leukemia and H1N1 virus have reported no deaths, some anectodal reports with low patient numbers have reported mortality rates as high as 28.5%. Here, we report patients with leukemia and H1N1 virus and review the literature. Methods: Medical records of all children with leukemia and H1N1 virus in our institution were reviewed for demographic, clinical, and laboratory data. We also carried out a systematic review of the English-language literature. Among the 24 articles found, only patients with leukemia and pandemic H1N1 infections were reviewed by two independent reviewers. Results: Eight of 98 children who received chemotherapy for leukemia were diagnosed with pandemic H1N1 infection. One developed pneumonia and acute respiratory distress syndrome (ARDS) and died. Another one developed hemophagocytic lymphohistiocytosis (HLH) and died due to secondary infection during the 6th week of treatment for HLH. In our study, 2 of 8 patients had a fatal course (25%), compared with an overall mortality of 2.5% in the studies retrieved from PubMed (6/232). Conclusion: Pandemic H1N1 influenza virus caused mortality in patients with ARDS or HLH; an unexpected finding for pandemic H1N1 (2009) influenza virus. Thus, for children with leukemia and infected with H1N1 virus, short-and long-term complications should be kept in mind during evaluation.
dc.language.isoeng
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectOnkoloji
dc.subjectPEDİATRİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleAnalysis of Fatal Cases of Pandemic Influenza A (H1N1) Virus Infections in Pediatric Patients with Leukemia
dc.typeMakale
dc.relation.journalPEDIATRIC HEMATOLOGY AND ONCOLOGY
dc.contributor.departmentIzmir Dr Behcet Uz Children''s Disease & Surgery Training & Research Hospital , ,
dc.identifier.volume30
dc.identifier.issue5
dc.identifier.startpage437
dc.identifier.endpage444
dc.contributor.firstauthorID210323


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster